Apo-Enalapril Caution For Usage





Full Prescribing Info
Caution For Usage
INFORMATION FOR PATIENTS: Angioedema: Angioedema, including laryngeal edema, may occur especially by following the first dose of enalapril. Patients should also be advised and told to report immediately any signs or symptoms suggesting angioedema (swelling of face, extremities, eyes, lips, tongue, difficulty in breathing) and take no more drug until they have consulted with the prescribing physician.
Hypotension: Patient should be cautioned to report lightheadedness especially during the first few days of therapy. If actual syncope occurs, the patients should be told to take no more drug until they have consulted with prescribing physician.
All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in blood pressure because of reduction in fluid volume. Other causes of volume depletion such as vomiting or diarrhea may also lead to fall in blood pressure; patients should be advised to consult with their physician.
Neutropenia: Patients should be told to report promptly and indication of infection (e.g. sore throat, fever) which may be a sign of neutropenia.
Impaired Liver Function: Patients should be advised to return to the physician if he/she experiences any symptoms possibly related to liver dysfunction, this would include "viral-like symptom" in the first weeks to months of therapy (such as fever, malaise, muscle pain, rash, or adenopathy which are possible indicators of hypersensitivity reactions), or if abdominal pain, nausea or vomiting, loss of appetite, jaundice, itching or any other unexplained symptoms occur during therapy.
Pregnancy: Since the use of APO-ENALAPRIL during pregnancy can cause injury and even death to the developing fetus, patients should be advised to report promptly to their physician of they become pregnant.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in